Neuroprotective effect of an antioxidant, lutein, during retinal inflammation

Mariko Sasaki, Yoko Ozawa, Toshihide Kurihara, Kousuke Noda, Yutaka Imamura, Saori Kobayashi, Susumu Ishida, Kazuo Tsubota

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

PURPOSE. Lutein has been the focus of recent study as a possible therapeutic approach for retinal diseases, but the molecular mechanism of its neuroprotective effect remains to be elucidated. The aim of this study was to investigate, with the use of a mouse endotoxin-induced uveitis (EIU) model, the neuroprotective effects of lutein against retinal neural damage caused by inflammation. METHODS. EIU was induced by intraperitoneal injection of lipopolysaccharide (LPS). Each animal was given a subcutaneous injection of lutein or vehicle three times: concurrently with and 3 hours before and after the LPS injection. Analysis was carried out 24 hours after EIU induction. Levels of rhodopsin protein and STAT3 activation were analyzed by immunoblotting. Lengths of the outer segments of the photoreceptor cells were measured. Dark-adapted full-field electroretinograms were recorded. Oxidative stress in the retina was analyzed by dihydroethidium and fluorescent probe. Expression of glial fibrillary acidic protein (GFAP) was shown immunohistochemically. RESULTS. The EIU-induced decrease in rhodopsin expression followed by shortening of the outer segments and reduction in a-wave amplitude were prevented by lutein treatment. Levels of STAT3 activation, downstream of inflammatory cytokine signals, and reactive oxygen species (ROS), which are both upregulated during EIU, were reduced by lutein. Pathologic change of Müller glial cells, represented by GFAP expression, was also prevented by lutein. CONCLUSIONS. The present data revealed that the antioxidant lutein was neuroprotective during EIU, suggesting a potential approach for suppressing retinal neural damage during inflammation.

Original languageEnglish
Pages (from-to)1433-1439
Number of pages7
JournalInvestigative Ophthalmology and Visual Science
Volume50
Issue number3
DOIs
Publication statusPublished - 2009 Mar

Fingerprint

Lutein
Neuroprotective Agents
Uveitis
Endotoxins
Antioxidants
Inflammation
Rhodopsin
Glial Fibrillary Acidic Protein
Lipopolysaccharides
STAT3 Transcription Factor
Retinal Diseases
Photoreceptor Cells
Subcutaneous Injections
Intraperitoneal Injections
Fluorescent Dyes
Immunoblotting
Neuroglia
Retina
Reactive Oxygen Species
Oxidative Stress

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience
  • Medicine(all)

Cite this

Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. / Sasaki, Mariko; Ozawa, Yoko; Kurihara, Toshihide; Noda, Kousuke; Imamura, Yutaka; Kobayashi, Saori; Ishida, Susumu; Tsubota, Kazuo.

In: Investigative Ophthalmology and Visual Science, Vol. 50, No. 3, 03.2009, p. 1433-1439.

Research output: Contribution to journalArticle

Sasaki, Mariko ; Ozawa, Yoko ; Kurihara, Toshihide ; Noda, Kousuke ; Imamura, Yutaka ; Kobayashi, Saori ; Ishida, Susumu ; Tsubota, Kazuo. / Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. In: Investigative Ophthalmology and Visual Science. 2009 ; Vol. 50, No. 3. pp. 1433-1439.
@article{1f156a65042a4126aea54db659e52da2,
title = "Neuroprotective effect of an antioxidant, lutein, during retinal inflammation",
abstract = "PURPOSE. Lutein has been the focus of recent study as a possible therapeutic approach for retinal diseases, but the molecular mechanism of its neuroprotective effect remains to be elucidated. The aim of this study was to investigate, with the use of a mouse endotoxin-induced uveitis (EIU) model, the neuroprotective effects of lutein against retinal neural damage caused by inflammation. METHODS. EIU was induced by intraperitoneal injection of lipopolysaccharide (LPS). Each animal was given a subcutaneous injection of lutein or vehicle three times: concurrently with and 3 hours before and after the LPS injection. Analysis was carried out 24 hours after EIU induction. Levels of rhodopsin protein and STAT3 activation were analyzed by immunoblotting. Lengths of the outer segments of the photoreceptor cells were measured. Dark-adapted full-field electroretinograms were recorded. Oxidative stress in the retina was analyzed by dihydroethidium and fluorescent probe. Expression of glial fibrillary acidic protein (GFAP) was shown immunohistochemically. RESULTS. The EIU-induced decrease in rhodopsin expression followed by shortening of the outer segments and reduction in a-wave amplitude were prevented by lutein treatment. Levels of STAT3 activation, downstream of inflammatory cytokine signals, and reactive oxygen species (ROS), which are both upregulated during EIU, were reduced by lutein. Pathologic change of M{\"u}ller glial cells, represented by GFAP expression, was also prevented by lutein. CONCLUSIONS. The present data revealed that the antioxidant lutein was neuroprotective during EIU, suggesting a potential approach for suppressing retinal neural damage during inflammation.",
author = "Mariko Sasaki and Yoko Ozawa and Toshihide Kurihara and Kousuke Noda and Yutaka Imamura and Saori Kobayashi and Susumu Ishida and Kazuo Tsubota",
year = "2009",
month = "3",
doi = "10.1167/iovs.08-2493",
language = "English",
volume = "50",
pages = "1433--1439",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "3",

}

TY - JOUR

T1 - Neuroprotective effect of an antioxidant, lutein, during retinal inflammation

AU - Sasaki, Mariko

AU - Ozawa, Yoko

AU - Kurihara, Toshihide

AU - Noda, Kousuke

AU - Imamura, Yutaka

AU - Kobayashi, Saori

AU - Ishida, Susumu

AU - Tsubota, Kazuo

PY - 2009/3

Y1 - 2009/3

N2 - PURPOSE. Lutein has been the focus of recent study as a possible therapeutic approach for retinal diseases, but the molecular mechanism of its neuroprotective effect remains to be elucidated. The aim of this study was to investigate, with the use of a mouse endotoxin-induced uveitis (EIU) model, the neuroprotective effects of lutein against retinal neural damage caused by inflammation. METHODS. EIU was induced by intraperitoneal injection of lipopolysaccharide (LPS). Each animal was given a subcutaneous injection of lutein or vehicle three times: concurrently with and 3 hours before and after the LPS injection. Analysis was carried out 24 hours after EIU induction. Levels of rhodopsin protein and STAT3 activation were analyzed by immunoblotting. Lengths of the outer segments of the photoreceptor cells were measured. Dark-adapted full-field electroretinograms were recorded. Oxidative stress in the retina was analyzed by dihydroethidium and fluorescent probe. Expression of glial fibrillary acidic protein (GFAP) was shown immunohistochemically. RESULTS. The EIU-induced decrease in rhodopsin expression followed by shortening of the outer segments and reduction in a-wave amplitude were prevented by lutein treatment. Levels of STAT3 activation, downstream of inflammatory cytokine signals, and reactive oxygen species (ROS), which are both upregulated during EIU, were reduced by lutein. Pathologic change of Müller glial cells, represented by GFAP expression, was also prevented by lutein. CONCLUSIONS. The present data revealed that the antioxidant lutein was neuroprotective during EIU, suggesting a potential approach for suppressing retinal neural damage during inflammation.

AB - PURPOSE. Lutein has been the focus of recent study as a possible therapeutic approach for retinal diseases, but the molecular mechanism of its neuroprotective effect remains to be elucidated. The aim of this study was to investigate, with the use of a mouse endotoxin-induced uveitis (EIU) model, the neuroprotective effects of lutein against retinal neural damage caused by inflammation. METHODS. EIU was induced by intraperitoneal injection of lipopolysaccharide (LPS). Each animal was given a subcutaneous injection of lutein or vehicle three times: concurrently with and 3 hours before and after the LPS injection. Analysis was carried out 24 hours after EIU induction. Levels of rhodopsin protein and STAT3 activation were analyzed by immunoblotting. Lengths of the outer segments of the photoreceptor cells were measured. Dark-adapted full-field electroretinograms were recorded. Oxidative stress in the retina was analyzed by dihydroethidium and fluorescent probe. Expression of glial fibrillary acidic protein (GFAP) was shown immunohistochemically. RESULTS. The EIU-induced decrease in rhodopsin expression followed by shortening of the outer segments and reduction in a-wave amplitude were prevented by lutein treatment. Levels of STAT3 activation, downstream of inflammatory cytokine signals, and reactive oxygen species (ROS), which are both upregulated during EIU, were reduced by lutein. Pathologic change of Müller glial cells, represented by GFAP expression, was also prevented by lutein. CONCLUSIONS. The present data revealed that the antioxidant lutein was neuroprotective during EIU, suggesting a potential approach for suppressing retinal neural damage during inflammation.

UR - http://www.scopus.com/inward/record.url?scp=62649169751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62649169751&partnerID=8YFLogxK

U2 - 10.1167/iovs.08-2493

DO - 10.1167/iovs.08-2493

M3 - Article

C2 - 18997089

AN - SCOPUS:62649169751

VL - 50

SP - 1433

EP - 1439

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 3

ER -